Marshall Wace LLP Buys 57,804 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Marshall Wace LLP grew its position in Trupanion, Inc. (NASDAQ:TRUP) by 6.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 901,645 shares of the financial services provider’s stock after acquiring an additional 57,804 shares during the period. Marshall Wace LLP owned 2.13% of Trupanion worth $43,459,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Baillie Gifford & Co. raised its position in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after purchasing an additional 147,341 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Trupanion by 458.3% during the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock worth $7,620,000 after buying an additional 129,782 shares during the period. Invesco Ltd. boosted its position in Trupanion by 122.0% during the 4th quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider’s stock worth $10,925,000 after buying an additional 124,549 shares during the period. Trexquant Investment LP grew its holdings in Trupanion by 229.3% during the 4th quarter. Trexquant Investment LP now owns 138,109 shares of the financial services provider’s stock worth $6,657,000 after acquiring an additional 96,174 shares during the last quarter. Finally, Hosking Partners LLP increased its position in Trupanion by 52.5% in the 4th quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider’s stock valued at $10,253,000 after acquiring an additional 73,203 shares during the period.

Trupanion Stock Performance

Shares of TRUP opened at $34.72 on Friday. The firm’s fifty day simple moving average is $36.92 and its two-hundred day simple moving average is $45.56. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $1.48 billion, a P/E ratio of -150.96, a price-to-earnings-growth ratio of 6.02 and a beta of 1.66.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. As a group, analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Activity

In other news, SVP Emily Dreyer sold 14,025 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the transaction, the senior vice president now owns 27,645 shares in the company, valued at approximately $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company’s stock, valued at approximately $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 29,792 shares of company stock worth $989,442 in the last quarter. 5.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

TRUP has been the topic of several analyst reports. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler reduced their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.